1. Actemra (tocilizumab): Genentech, Inc. https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/125276s092lbl.pdf. Accessed Aug 2022
2. Aguilera B, Perez Gomez J, DeGrazia D (2021) Should biomedical research with great apes be restricted? A systematic review of reasons. BMC Med Ethics 22:15
3. Ali S, Kolter K (2019) Kolliphor® HS 15 – an enabler for parenteral and oral formulations. Am Pharm Rev, 25 Feb 2019. https://www.americanpharmaceuticalreview.com/Featured-Articles/358749-Kolliphor-HS-15-An-Enabler-for-Parenteral-and-Oral-Formulations/. Accessed July 2022
4. Allio T (2018) The FDA animal rule and its role in protecting human safety. Expert Opin Drug Saf 17(10):971–973
5. Animals (Scientific Procedures) Act 1986 Amendment Regulations (2012) https://www.legislation.gov.uk/ukdsi/2012/9780111530313. Accessed July 2022